Stephen Lundy resigned as CEO and director of Bioptix Inc., effective April 6.

Lundy's resignation was not the result of any disagreement with the company, any matter related to its operations, policies or practices, its management or the board.

Also effective April 6, Bioptix appointed Michael Beeghley as CEO to fill the vacancy created by Lundy's resignation. Beeghley currently serves as the chairman of the board.